Evidence map›Paper›PMID 25729215›Full record

ArticleMediators of inflammation2015

Autophagy upregulation and apoptosis downregulation in DAHP and triptolide treated cerebral ischemia.

Yang Yang, Keqiang Gao, Zhiying Hu, Weiyun Li, Henry Davies, Shucai Ling, John A Rudd, Marong Fang

Open access · goldAbstract read
In one paragraph

Article in Mediators of inflammation, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
14.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 53 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. Review
  8. Review
  9. Article
  10. Review
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Triptolide, A Potential Autophagy Modulator.Chinese journal of integrative medicine · 2019
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Yang YangInstitute of Neuroscience, Zhejiang University School of Medicine, Hangzhou 310058, China.
Keqiang GaoInstitute of Neuroscience, Zhejiang University School of Medicine, Hangzhou 310058, China.
Zhiying HuDepartment of Obstetrics and Gynecology, Hangzhou Red Cross Hospital, Hangzhou 310003, China.
Weiyun LiInstitute of Neuroscience, Zhejiang University School of Medicine, Hangzhou 310058, China.
Henry DaviesInstitute of Neuroscience, Zhejiang University School of Medicine, Hangzhou 310058, China.
Shucai LingInstitute of Neuroscience, Zhejiang University School of Medicine, Hangzhou 310058, China.
John A RuddSchool of Biomedical Sciences, Faculty of Medicine, The Chinese University of Hong Kong, Shatin, New Territories, Hong Kong.
Marong FangInstitute of Neuroscience, Zhejiang University School of Medicine, Hangzhou 310058, China.
Zhejiang University · CNChinese University of Hong Kong · CNHangzhou Red Cross Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

It has previously been demonstrated that ischemic stroke activates autophagy pathways; however, the mechanism remains unclear. The aim of this study is to further investigate the role that autophagy plays in cerebral ischemia. 2, 4-diamino-6-hydroxy-pyrimidine (DAHP), for its nitric oxide synthase (NOS) inhibiting neuroprotective effect, and triptolide (TP), for its anti-inflammatory property, were selected to administer pre middle cerebral artery occlusion (MCAO). The drugs were administered 12 hours prior to MCAO. Both magnetic resonance imaging (MRI) and 2, 3, 5-triphenyltetrazolium chloride (TTC) staining showed that the drugs reduce the area of infarction. Immunoblotting analysis revealed increases in Beclin-1 and myeloid cell leukelia-1(Mcl-1) in treated rats. This could be a contributing factor to the reduction in autophagy induced damage. Immunochemistry and western blot showed that mTOR expression in treated rats was marginally different 24 h after injury, and this could also be significant in the mechanism. Furthermore, terminal deoxynucleotidyl transferase- (TdT-) mediated dUTP nick end labeling (TUNEL) staining proved that the drugs are effective in reducing apoptosis. The upregulation of Beclin-1 and Mcl-1 and downregulation of Bcl-2, caspase-3, and the Bcl-2/Beclin-1 ratio infer that the neuroprotective effect of DAHP and TP act via the mediation of autophagy and apoptosis pathways.

Indexed as

AnimalsApoptosisAutophagyBlotting, WesternBrain IschemiaDiterpenesEpoxy CompoundsImmunohistochemistryIn Situ Nick-End LabelingMagnetic Resonance SpectroscopyMalePhenanthrenesRatsRats, Sprague-DawleySugar Acids5-dehydro-3-deoxy-D-arabino-heptulosonic acid-7-phosphateDiterpenesEpoxy CompoundsPhenanthrenesSugar Acidstriptolide

Identifiers

PMID25729215
PMCPMC4333273
OpenAlexW2087534449

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.